HomeSVE • WSE
add
Synthaverse SA
Previous close
zł 5.03
Day range
zł 4.97 - zł 5.05
Year range
zł 3.95 - zł 5.93
Market cap
355.98M PLN
Avg Volume
123.78K
P/E ratio
-
Dividend yield
-
Primary exchange
WSE
Market news
Financials
Income Statement
Revenue
Net income
| (PLN) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 13.43M | -3.40% |
Operating expense | 8.34M | 12.85% |
Net income | -538.00K | -36.55% |
Net profit margin | -4.01 | -41.70% |
Earnings per share | — | — |
EBITDA | 3.35M | 108.91% |
Effective tax rate | -2,141.67% | — |
Balance Sheet
Total assets
Total liabilities
| (PLN) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.00K | -99.97% |
Total assets | 298.65M | 2.38% |
Total liabilities | 177.72M | -0.98% |
Total equity | 120.93M | — |
Shares outstanding | 70.77M | — |
Price to book | 2.94 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (PLN) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -538.00K | -36.55% |
Cash from operations | 8.68M | 55.44% |
Cash from investing | -2.89M | -124.69% |
Cash from financing | -6.54M | -237.93% |
Net change in cash | -757.00K | -108.38% |
Free cash flow | — | — |
About
Biomed-Lublin Wytwórnia Surowic i Szczepionek is a Polish pharmaceutical company operating since 1944. The company manufactures medicinal preparations. The company's headquarters is in Lublin. Wikipedia
Founded
1944
Website
Employees
231
